BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Biotech Beach

  Dexcom Announces Upcoming Conference Presentation - May 29, 2024

  DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the William Blair 44th Annual Growth Stock Conference on Wednesday, June 5th.

  May 29, 2024

   · 

  1 min read
• Business

  Aptar Digital Health and Iona Mind Announce Partnership to Deliver Scalable Mental Health Support to Chronic Disease Patients

  Aptar Digital Health today announced a partnership to help support patients with chronic diseases to manage their psychological stress and emotional wellbeing.

  May 29, 2024

   · 

  5 min read
• Biotech Bay

  Vistagen to Present at the Jefferies Global Healthcare Conference

  Vistagen today announced that company management will present and host one-on-one meetings during the Jefferies Global Healthcare Conference taking place June 5 and 6, 2024 in New York City.

  May 29, 2024

   · 

  1 min read
• Business

  Entact Bio Appoints Michael Gutch, Ph.D., as Chief Operating Officer

  Entact Bio today announced the appointment of Michael Gutch, Ph.D., as Chief Operating Officer.

  May 29, 2024

   · 

  3 min read
• Biotech Bay

  Long-Term Data from Mirum’s LIVMARLI Studies in ALGS and PFIC to be Presented at EASL Congress

  Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that new analyses from long-term treatment with LIVMARLI will be presented at the European Association for the Study of the Liver (EASL) Annual Congress taking place June 5-8, 2024, in Milan, Italy.

  May 29, 2024

   · 

  7 min read
• Protalix BioTherapeutics to Present at the 2024 BIO International Convention

  Protalix BioTherapeutics, Inc. announced that Dror Bashan, its President and Chief Executive Officer, will present at the upcoming 2024 BIO International Convention June 3 - 6, 2024, in San Diego, California.

  May 29, 2024

   · 

  3 min read
• BioMidwest

  New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years

  Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.

  May 29, 2024

   · 

  5 min read
• Pharm Country

  Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier

  Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced the first third-party reimbursement from a major insurance carrier for the Company’s Portable Neuromodulation Stimulator device.

  May 29, 2024

   · 

  5 min read
• BioMidwest

  Best Peptides Company of 2024 Announced As Limitless Biotech

  Limitless Biotech, a leading provider of high-quality peptides, proudly announces its ascension as the best peptide company in the industry.

  May 29, 2024

   · 

  2 min read
• Business

  ValGenesis and Autocal Announce Strategic Alliance to Strengthen Quality and Compliance for Life Sciences in India

  ValGenesis Inc. and Autocal Solutions Pvt. Ltd. have entered into a strategic partnership to address quality assurance and compliance challenges in the life sciences industry in India.

  May 29, 2024

   · 

  3 min read